ELEMENTIS PLC/ADR (OTCMKTS:ELMTY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday, Zacks.com reports.

According to Zacks, “Elementis plc is a specialty chemicals company. Its business comprises of Specialty Products, Chromium and Surfactants. The company’s product consists of BENTONE(R) organoclays, RHEOLATE(R) rheological additives, DAPRO(R) specialty additives, M-P-A(R) anti-settling agents, NALZIN(R) corrosion and rust inhibitors, THIXATROL(R) rheology additives, NUOSPERSE(R) wetting and dispersing agents, TINT-AYD (R)colorants, SLIP-AYD(R) waxes and slip additives, SERDOX(R) polyglycol ethers, SERDOLAMIDE(R) alkanolamides and SERVOXYL(R) phosphate esters. Elementis plc is based in London, United Kingdom. “

Shares of OTCMKTS:ELMTY traded up $0.51 during mid-day trading on Tuesday, reaching $7.51. 500 shares of the stock were exchanged. The company has a quick ratio of 1.43, a current ratio of 2.56 and a debt-to-equity ratio of 0.65. The company has a market cap of $871.16 million, a P/E ratio of 11.04 and a beta of 0.95. ELEMENTIS PLC/ADR has a one year low of $6.82 and a one year high of $13.83. The stock’s 50 day simple moving average is $7.02 and its 200-day simple moving average is $7.96.

About ELEMENTIS PLC/ADR

Elementis plc manufactures and sells specialty chemicals in North and South America, Europe, and Asia. It operates through Specialty Products and Chromium segments. The Specialty Products segment offers functional additives to the personal care, coatings, and energy end markets, as well as oilfield and construction sectors.

Featured Story: What is a short straddle?

Get a free copy of the Zacks research report on ELEMENTIS PLC/ADR (ELMTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ELEMENTIS PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEMENTIS PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.